These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8966136)

  • 1. [Nonconventional therapy in a case of systemic juvenile rheumatoid arthritis].
    Cocchi P; Calabri G; Salvi G; Cocchi C
    Pediatr Med Chir; 1996; 18(3):319-20. PubMed ID: 8966136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome in juvenile rheumatoid arthritis in India.
    Aggarwal A; Agarwal V; Danda D; Misra R
    Indian Pediatr; 2004 Feb; 41(2):180-4. PubMed ID: 15004305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longterm auranofin therapy in patients with juvenile rheumatoid arthritis.
    Giannini EH; Brewer EJ; Person DA; He XH
    J Rheumatol; 1986 Aug; 13(4):768-70. PubMed ID: 3534260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antirheumatic effects of first-line agents in the treatment of juvenile chronic arthritis.
    Ailioaie C; Lupuşoru-Ailioaie LM
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):134-8. PubMed ID: 10756785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy of juvenile rheumatoid arthritis with hydroxychloroquine-gold-methotrexate: a pilot study.
    Lomater G; Gattinara M; Gerloni V; Zeni S; Fantini F
    Acta Univ Carol Med (Praha); 1994; 40(1-4):109-12. PubMed ID: 9355684
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years.
    Flatø B; Lien G; Smerdel A; Vinje O; Dale K; Johnston V; Sørskaar D; Moum T; Ploski R; Førre Ø
    J Rheumatol; 2003 Feb; 30(2):386-93. PubMed ID: 12563700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Infantile JRA and ACTH therapy].
    Obata T; Akasawa A; Iikura Y
    Ryumachi; 1989 Feb; 29(1):45-51. PubMed ID: 2545000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Update drug therapy of juvenile rheumatoid arthritis].
    Watanabe N
    Ryumachi; 1996 Aug; 36(4):670-5. PubMed ID: 8911086
    [No Abstract]   [Full Text] [Related]  

  • 9. Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.
    Kimura Y; Pinho P; Walco G; Higgins G; Hummell D; Szer I; Henrickson M; Watcher S; Reiff A
    J Rheumatol; 2005 May; 32(5):935-42. PubMed ID: 15868633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study.
    Gerloni V; Pontikaki I; Gattinara M; Desiati F; Lupi E; Lurati A; Salmaso A; Fantini F
    Arthritis Rheum; 2005 Feb; 52(2):548-53. PubMed ID: 15693004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate in juvenile idiopathic arthritis: answers and questions.
    Ravelli A; Martini A
    J Rheumatol; 2000 Aug; 27(8):1830-3. PubMed ID: 10955319
    [No Abstract]   [Full Text] [Related]  

  • 12. [Two cases with SLE and MCTD developed after a long period of chronic arthritis that was initially diagnosed as JRA].
    Takei S; Maeno N; Shigemori M; Nakae Y; Mori H; Nerome Y; Imanaka H; Hokonohara M; Miyata K
    Ryumachi; 1997 Oct; 37(5):702-8. PubMed ID: 9396373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid myopathy in a child with juvenile rheumatoid arthritis. Case report.
    Genel F; Arslanoglu S; Hizarcioglu M; Durmaz B; Uran N; Aktaş S
    Panminerva Med; 2003 Mar; 45(1):75-7. PubMed ID: 12682624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis.
    Ramanan AV; Schneider R
    J Rheumatol; 2003 Feb; 30(2):401-3. PubMed ID: 12563702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
    Zeft A; Hollister R; LaFleur B; Sampath P; Soep J; McNally B; Kunkel G; Schlesinger M; Bohnsack J
    J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis.
    Bowyer SL; Roettcher PA; Higgins GC; Adams B; Myers LK; Wallace C; Rennebohm R; Moore TL; Pepmueller PH; Spencer C; Wagner-Weiner L; Rabinovich E; Passo M; Lovell DJ; McCurdy D; Zemel L; Schikler KN; Szer I; Kurtin P; Lindsley C
    J Rheumatol; 2003 Feb; 30(2):394-400. PubMed ID: 12563701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sandimmun-Neoral--a new quality of life for patients with severe systemic juvenile rheumatoid arthritis].
    Alekseeva EI; Shakhbazian IE
    Ter Arkh; 1999; 71(5):26-9. PubMed ID: 10399226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis.
    Narváez J; Díaz-Torné C; Juanola X; Geli C; Llobet JM; Nolla JM; Díaz-López C
    Ann Rheum Dis; 2009 Apr; 68(4):607-8. PubMed ID: 19286909
    [No Abstract]   [Full Text] [Related]  

  • 19. [Methotrexate treatment in refractory juvenile rheumatoid arthritis].
    Brik R
    Harefuah; 1998 Dec; 135(11):509-11, 567. PubMed ID: 10911466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations.
    Foell D; Wittkowski H; Hammerschmidt I; Wulffraat N; Schmeling H; Frosch M; Horneff G; Kuis W; Sorg C; Roth J
    Arthritis Rheum; 2004 Apr; 50(4):1286-95. PubMed ID: 15077313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.